Sex-Related Differences in Outcome After High-Risk Vascular Surgery After the Administration of β-Adrenergic-Blocking Drugs

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 3, 2008, Pages 354-360

  Matyal, Robina ^a   Mahmood, Feroze ^a   Panzica, Peter ^a   Pomposelli, Frank ^a   Park, Kyung W ^a   Hamden, Allen ^a   Schermerhorn, Mark ^a   Hess, Philip ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adrenergic blocking drugs; outcome; sex; vascular surgery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; LABETALOL; METOPROLOL;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SURGICAL RISK; TREATMENT OUTCOME; VASCULAR SURGERY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 44149113233     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.12.021     Document Type: Article

References (32)

1. Mangano D.T., Wong M.G., London M.J., et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery-II: Incidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol 17 (1991) 851-857
2. Raby K.E., Goldman L., Creager M.A., et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 321 (1989) 1296-1300
3. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 (1999) 1789-1794
4. Raby K.E., Barry J., Creager M.A., et al. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. JAMA 268 (1992) 222-227
5. Mackey W.C., Fleisher L.A., Haider S., et al. Perioperative myocardial ischemic injury in high-risk vascular surgery patients: Incidence and clinical significance in a prospective clinical trial. J Vasc Surg 43 (2006) 533-538
6. Auerbach A.D., and Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: Clinical applications. JAMA 287 (2002) 1445-1447
7. Lindenauer P.K., Pekow P., Wang K., et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
8. Mangano D.T., Layug E.L., Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 (1996) 1713-1720
9. Hannan E.L., Bernard H.R., Kilburn Jr. H.C., et al. Gender differences in mortality rates for coronary artery bypass surgery. Am Heart J 123 (1992) 866-872
10. Ridker P.M., Cook N.R., Lee I.M., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 (2005) 1293-1304
11. White W.B., Johnson M.F., Black H.R., et al. Gender and age effects on the ambulatory blood pressure and heart-rate responses to antihypertensive therapy. Am J Hypertens 14 (2001) 1239-1247
12. Luzier A.B., Killian A., Wilton J.H., et al. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther 66 (1999) 594-601
13. Schaefer B.M., Caracciolo V., Frishman W.H., et al. Gender, ethnicity, and genes in cardiovascular disease. Part 2: Implications for pharmacotherapy. Heart Dis 5 (2003) 202-214
14. Gleiter C.H., and Gundert-Remy U. Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet 21 (1996) 123-128
15. Kando J.C., Yonkers K.A., and Cole J.O. Gender as a risk factor for adverse events to medications. Drugs 50 (1995) 1-6
16. Meibohm B., Beierle I., and Derendorf H. How important are gender differences in pharmacokinetics?. Clin Pharmacokinet 41 (2002) 329-342
17. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery-Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 94 (2002) 1052-1064
18. Slogoff S., and Keats A.S. Does perioperative myocardial ischemia lead to postoperative myocardial infarction?. Anesthesiology 62 (1985) 107-114
19. Fletcher A., Beevers D.G., Bulpitt C., et al. Beta-adrenoceptor blockade is associated with increased survival in male but not female hypertensive patients: A report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens 2 (1988) 219-227
20. Raby K.E., Brull S.J., Timimi F., et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88 (1999) 477-482
21. Devereaux P.J., Beattie W.S., Choi P.T., et al. How strong is the evidence for the use of perioperative beta-blockers in noncardiac surgery?. Systematic review and meta-analysis of randomised controlled trials. BMJ 331 (2005) 313-321
22. Boersma E., Poldermans D., Bax J.J., et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285 (2001) 1865-1873
23. Gottlieb S.S., McCarter R.J., and Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339 (1998) 489-497
24. Stone J.G., Foex P., Sear J.W., et al. Myocardial ischemia in untreated hypertensive patients: Effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 68 (1988) 495-500
25. Wallace A., Layug B., Tateo I., et al., McSPI Research Group. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 88 (1998) 7-17
26. Wiesbauer F., Schlager O., Domanovits H., et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: A systematic review and meta-analysis. Anesth Analg 104 (2007) 27-41
27. Yang H., Raymer K., Butler R., et al. The effects of perioperative beta-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152 (2006) 983-990
28. Garg R., Yusuf S., and Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273 (1995) 1450-1456
29. Levin R.I. The puzzle of aspirin and sex. N Engl J Med 352 (2005) 1366-1368
30. Rathore S.S., Wang Y., and Krumholz H.M. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347 (2002) 1403-1411
31. Walle T., Walle U.K., Cowart T.D., et al. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther 46 (1989) 257-263
32. Lim J.G., Shapiro E.P., Vaidya D., et al. Sex differences in left ventricular function in older persons with mild hypertension. Am Heart J 150 (2005) 934-940